Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab.
<h4>Background</h4>There is increasing concern about the risk of latent tuberculosis infection (LTBI) reactivation during the use of biologics for psoriasis. Although ustekinumab had been documented with low risk of tuberculosis, the long-term follow-up of LTBI as determined by QuantiFER...
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0184178&type=printable |
